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MIALIGNANT FIBROUS HISTIOCYTOIVlA OF THE HEART PRODUCING INTERLEUKIN-6 
Hajime Matsue, MD, a Tetsuo Sakakibara, MD, a Ryousuke Matsuwaka, MD, ~ Masataka Mitsuno, MD, ~ 
Masahiko Tsujimoto, MD, b and Norihiro Nishimoto, MD, c Osaka, Japan 
Malignant fibrous histiocytoma (MFH) is one of the 
most common soft tissue sarcomas. However, MFH is 
uncommon as a primary cardiac tumor. Here we report a 
case of primary MFH of the heart producing the inflam- 
matory cytokine interleukin-6 (IL-6). 
Clinical summary. A 54-year-old man was admitted 
to our hospital with high fever and arthralgia of the 
lower extremities of 1 month's duration. Examination 
showed severe edema of the face and extremities. He 
became orthopneic and his cardiac status deteriorated 
to New York Heart Association functional class IV 
soon after admission. Laboratory tests gave the follow- 
ing data showing severe inflammation: the leukocyte 
count was 14.9 × 103//zl, the C-reactive protein level 
was 23.37 mg/dl, and the serum IL-6 level, measured by 
chemiluminescent enzyme immunoassay (Human IL-6 
CLEIA, Fujirebio Corp., Tokyo, Japan), was an ex- 
tremely high 61.4 pg/ml (normal range: 0 to 3.0 pg/ml). 
The electrocardiogram showed atrial fibrillation. Trans- 
thoracic and transesophageal echocardiography re- 
vealed a huge tumor in the left atrium, which was 
attached to the intraatrial septum and extended to the 
anterior leaflet of the mitral valve (Fig. 1). Other 
examinations revealed no abnormalities. Because of 
these data, a cardiac myxoma was strongly suspected. 
The tumor was excised via the transseptal superior 
approach with the aid of cardiopulmonary b pass. The 
mass was removed piecemeal with the involved portion 
of the intraatrial septum, and the resulting defect was 
repaired with a polytetrafluoroethylene cardiovascular 
patch.* The tumor measured 8 × 4 × 3 cm and its 
surface was irregular. On sectioning, it was a solid 
lesion with areas of necrosis. Malignancy was diagnosed 
by the intraoperative pathologic examination. The early 
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postoperative period was uneventful. The fever re- 
solved and the arthralgia nd edema disappeared. The 
C-reactive protein level was 10.57 mg/dl and serum IL-6 
was 29.9 pg/ml 3 weeks after the operation. On culture 
of tumor cells, IL-6 release into the supernatant was 
2600 ng/ml in 8 hours. Microscopic examination re- 
vealed poorly differentiated tumor cells with hyperchro- 
matic and pleomorphic nuclei, spindle-shaped cells 
arranged in a stria pattern, and multinucleated giant 
cells (Fig. 2, A). Immunostaining with an antibody to 
%-antichymotrypsin howed dark reaction products in 
some of the tumor cells (Fig. 2, B). From these histo- 
logic findings, the tumor was finally diagnosed as MFH 
of the heart. Adjunctive radiation therapy to the left 
atrium was then performed. 
On postoperative day 40, high fever and edema again 
developed. Transthoracic echocardiography showed local 
recurrence of the tumor in the left atrium. Laboratory 
tests showed a leukocyte count of 10.9 × 103//,1, a 
C-reactive protein level of 25.82 mg/dl, and a serum IL-6 
level of 133.7 pg/ml. He died of left heart failure on 
postoperative day 70. Autopsy revealed a recurrent tumor 
occupying a large part of the left atrium and obstructing 
the mitral valve, with metastases to the bilateral adrenal 
glands and the right foot. 
Comment. It was recently reported that cardiac myx- 
oma cells produced IL-6, which could cause a systemic 
inflammatory response, including fever, arthralgia, and 
increased levels of acute-phase proteins. ~'2 Soeparwata 
and colleagues 3 reported asignificant correlation between 
the serum IL-6 level and tumor size and stated that 
constitutional symptoms appeared at an IL-6 level of 9 
pg/ml or more. Because our patient had a tumor in the left 
atrium and inflammatory manifestations, we thought of 
the possibility of increased serum levels of inflammatory 
cytokines. As we expected, the IL-6 level in serum and 
tumor cell culture supernatant was extremely high, and 
the serum 1L-6 level decreased after tumor resection and 
increased again at the time of recurrence. These findings 
indicated that the patient's tumor produced IL-6. Thus 
measurement of inflammatory cytokines such as IL-6 
might be helpful to clarify the pathophysiology when a 
cardiac tumor is found in association with constitutional 
signs and symptoms. 
MFH is the most common soft tissue sarcoma rising 
from various organs, but primary MFH of the heart is 
extremely unusual. 4 According to a review of the litera- 
ture on primary MFH of the heart, 22 of 26 tumors were 
in the left atrium, and the prognosis of 14 patients having 
surgical resection was very poor. s it appears that cardiac 
MFH should be resected as radically as possible, but no 
standard adjuvant chemotherapy or irradiation regimen 
has been developed because this tumor is extremely 
uncommon. 5 So far as we know, there has been no 
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Fig. 1. Transesophageal echocardiogram showed a huge tumor (T) in the left atrium (LA), which was 
attached to the intraatrial septum and extended to the anterior leaflet of the mitral valve (MV). LV, Left 
ventricle; RA, right atrium, RV, right ventricle. 
Fig. 2. A, Hematoxylin-eosin-stained section showing poorly differentiated tumor cells with a striated 
pattern (arrow) and a multinucleated giant cell (alrowheacl). B, Immunostained section showing cq- 
antichymotrypsin positive cells (arrow). 
previous report of cardiac MFH producing 1L-6, as in our 
case. The fact that local recurrence developed soon after 
the operation in our case suggests that a more extensive 
operation may have been desirable, such as total resection 
and replacement of the intraatrial septum. Heart trans- 
plantation is a yet more radical treatment than conven- 
tional tumor resection, although the use of donor hearts 
for patients with a possibly poor prognosis i the subject of 
controversy. Partial or total cardiac replacement with the 
use of sophisticated artificial technology may be an option 
in the future. 
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LEFT THORACODORSAL ARTERY AS AN INFLOW GRAFT FOR MINIMALLY INVASIVE DIRECT 
CORONARY ARTERY BYPASS GRAFTING 
Go Watanabe, MD, Takuro Misaki, MD, Keijyu Kotoh, MD, and Katsushi Ueyama, MD, Toyama, Japan 
The thoracodorsal rtery (TDA) is one of the branches 
of the subscapular tery that is the largest branch of the 
axillary artery. It arises from the third part of the axillary 
artery and runs in a downward and medial direction along 
the anterior border of the subscapularis and under the 
cover of the latissimus dorsi muscle. In the field of 
dynamic ardiomyoplasty and plastic surgery, the TDA 
has been used to supply muscle or musculocutaneous 
flap]' 2 The TDA has an attractive caliber and length as 
an arterial graft. We report the first case in which an in 
situ TDA was used as an inflow graft for myocardial 
revascularization. 
The patient was a 68-year-old woman with a history 
of increasing postinfarction angina and cerebral infarc- 
tion. Cardiac catheterization revealed 90% stenoses of 
the proximal left anterior descending artery (LAD) and 
of an obtuse marginal branch of circumflex coronary 
artery (OM). Minimally invasive coronary artery bypass 
grafting (MIDCAB) through a small thoracotomy via 
the left internal thoracic artery (LITA) and the right 
gastroepiploic artery was planned to revascularize the 
LAD and OM. However, the preoperative angiogram 
had shown total occlusion of the celiac artery. We 
decided to avoid grafting the right gastroepiploic artery. 
We concluded that the left TDA could be used as an 
inflow graft to bypass the OM. The patient was placed 
in the right lateral position; the LITA was harvested 
thoracoscopically as a pedicle with the use of video 
imaging guidance. An incision of approximately 3 cm 
was made over the fourth intercostal space along the 
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Fig. 1. The minithoracotomy consisted of limited lateral 
thoracotomy incision in the fifth intercostal space (ICS) 
and small axillary incision for the left thoracodorsal rtery 
(LTDA) harvesting. LDM, Latissimus dorsi muscle. 
anterior margin of the left latissimus dorsi muscle (Fig. 
1). The TDA courses between the latissimus dorsi 
muscle and the serratus anterior muscle and was easily 
visualized when the latissimus dorsi muscle was re- 
tracted laterally. We carefully isolated 8 cm of the 
TDA. The diameters of the distal portion of the TDA 
were 2.5 mm. The size and quality of this artery were 
similar to those of the LITA in this case. A limited 
lateral thoracotomy incision was performed in the fifth 
intercostal space; thereafter, the right radial artery 
(RA) was also harvested. The left TDA was divided 
distally after heparinization and anastomosed to the 
free RA with an 8-0 suture. The TDA-RA composite 
graft was introduced through the fourth intercostal 
space via the major fissure of the left lung. Stay sutures 
